RESPONSE BIOMEDICAL CORP·4

Jun 20, 5:51 PM ET

RESPONSE BIOMEDICAL CORP 4

4 · RESPONSE BIOMEDICAL CORP · Filed Jun 20, 2013

Insider Transaction Report

Form 4
Period: 2013-06-18
Wang David
Director
Transactions
  • Award

    Restricted Share Units

    2013-06-18+5,0195,019 total
    Common Stock (5,019 underlying)
Footnotes (2)
  • [F1]Each restricted share unit represents a contingent right to receive one share of the company's common stock.
  • [F2]100% of the restricted share units vested on the date of grant. The expiration date for each of the restricted share units will be the later of three (3) years after the effective date or two (2) years following the grantee's termination date.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    PRIMARY DOCUMENT